Ornithine-δ-aminotransferase clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Gyrate Atrophy Ocular and Systemic Study
open to eligible people ages 12 years and up
The Gyrate Atrophy Ocular and Systemic Study characterizes the natural history of ornithine levels and retinal degeneration (RD) associated with disease-causing OAT variants in the presence of standard care dietary treatment regimens over 4 years. The research goal is to understand the impact of OAT mutations on plasma ornithine levels and retinal degeneration. Funding Source- FDA OOPD
at UCSF
Last updated: